JP7073256B2 - ラクトバチルス・プランタルム２８３０（ｅｃｇｃ１３１１０４０２）を含む組成物 - Google Patents

ラクトバチルス・プランタルム２８３０（ｅｃｇｃ１３１１０４０２）を含む組成物 Download PDF

Info

Publication number
JP7073256B2
JP7073256B2 JP2018517343A JP2018517343A JP7073256B2 JP 7073256 B2 JP7073256 B2 JP 7073256B2 JP 2018517343 A JP2018517343 A JP 2018517343A JP 2018517343 A JP2018517343 A JP 2018517343A JP 7073256 B2 JP7073256 B2 JP 7073256B2
Authority
JP
Japan
Prior art keywords
lactobacillus plantarum
composition
composition according
ldl
levels
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2018517343A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018531598A (ja
JP2018531598A5 (enExample
Inventor
ステファン パトリック オハラ
Original Assignee
オプティバイオティクス リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by オプティバイオティクス リミテッド filed Critical オプティバイオティクス リミテッド
Publication of JP2018531598A publication Critical patent/JP2018531598A/ja
Publication of JP2018531598A5 publication Critical patent/JP2018531598A5/ja
Application granted granted Critical
Publication of JP7073256B2 publication Critical patent/JP7073256B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
JP2018517343A 2015-11-02 2016-11-02 ラクトバチルス・プランタルム２８３０（ｅｃｇｃ１３１１０４０２）を含む組成物 Active JP7073256B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1519326.1 2015-11-02
GBGB1519326.1A GB201519326D0 (en) 2015-11-02 2015-11-02 Composition`
PCT/GB2016/053389 WO2017077285A1 (en) 2015-11-02 2016-11-02 Composition comprising lactobacillus plantarum 2830 (ecgc 13110402)

Publications (3)

Publication Number Publication Date
JP2018531598A JP2018531598A (ja) 2018-11-01
JP2018531598A5 JP2018531598A5 (enExample) 2019-12-19
JP7073256B2 true JP7073256B2 (ja) 2022-05-23

Family

ID=55130539

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018517343A Active JP7073256B2 (ja) 2015-11-02 2016-11-02 ラクトバチルス・プランタルム２８３０（ｅｃｇｃ１３１１０４０２）を含む組成物

Country Status (7)

Country Link
US (1) US10898528B2 (enExample)
EP (1) EP3370746B1 (enExample)
JP (1) JP7073256B2 (enExample)
AU (1) AU2016348840B2 (enExample)
CA (1) CA3001472A1 (enExample)
GB (1) GB201519326D0 (enExample)
WO (1) WO2017077285A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201319540D0 (en) * 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition
GB201611782D0 (en) * 2016-07-06 2016-08-17 Optibiotix Ltd Composition
CN110760456B (zh) * 2019-07-09 2022-03-22 怀化学院 一种用于降解胆固醇的植物乳杆菌La1及其应用
CN116286534B (zh) * 2023-03-22 2023-11-17 东北农业大学 用于缓解高尿酸血症的植物乳植杆菌及其复合物和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015067948A1 (en) 2013-11-05 2015-05-14 Optibiotix Limited Composition
WO2015067947A1 (en) 2013-11-05 2015-05-14 Optibiotix Limited Composition comprising lactobacillus plantarum

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100436355B1 (ko) * 2001-08-14 2004-06-18 박정호 항산화물질, 옥타코사놀 및 베타글루칸을 함유한 발효음료및 그의 제조방법
WO2015149818A1 (en) * 2014-04-03 2015-10-08 Oü Tervisliku Piima Biotehnoloogiate Arenduskeskus (Bio-Competence Centre Of Healthy Dairy Products) Lactobacillus plantarum inducia strain dsm 21379 as hypocholesterolemic agent and antimicrobial agent against clostridium difficile
CN102031229B (zh) * 2009-09-24 2012-05-30 家医国际生化股份有限公司 具有肠胃道吸附能力及排除胆固醇能力的植物乳杆菌
EP2311473A1 (en) * 2009-10-09 2011-04-20 AB-Biotics Producciones Industriales De Microbiotas, S.L. Lactobacillus plantarum strains as probiotics
TWI463986B (zh) * 2012-08-29 2014-12-11 Univ China Medical 胚芽乳酸桿菌ｃｍｕ９９５菌株之新用途
CN105105145B (zh) * 2015-09-14 2022-04-22 吉林省命之元生物科技有限公司 一株植物乳杆菌及其在制备降血糖血脂的功能性食品中的应用

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015067948A1 (en) 2013-11-05 2015-05-14 Optibiotix Limited Composition
WO2015067947A1 (en) 2013-11-05 2015-05-14 Optibiotix Limited Composition comprising lactobacillus plantarum

Also Published As

Publication number Publication date
WO2017077285A1 (en) 2017-05-11
EP3370746B1 (en) 2021-03-10
AU2016348840A1 (en) 2018-04-26
JP2018531598A (ja) 2018-11-01
EP3370746A1 (en) 2018-09-12
AU2016348840B2 (en) 2023-07-20
CA3001472A1 (en) 2017-05-11
US20180318364A1 (en) 2018-11-08
GB201519326D0 (en) 2015-12-16
US10898528B2 (en) 2021-01-26

Similar Documents

Publication Publication Date Title
US6811786B1 (en) Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions
EP2481299B1 (en) Bifidobacterium bifidum strains for application in gastrointestinal diseases
US11903979B2 (en) Composition comprising Lactobacillus plantarum 2830 (ECGC 13110402)
EP1067945A2 (en) Methods for reducing cholesterol using bacillus coagulans spores, systems and compositions
CN103582486A (zh) 具有抗氧化活性的益生菌及其用途
CA2583668A1 (en) Synbiotics
Majeed et al. Cranberry seed fibre: a promising prebiotic fibre and its fermentation by the probiotic Bacillus coagulans MTCC 5856
JP7073256B2 (ja) ラクトバチルス・プランタルム２８３０（ｅｃｇｃ１３１１０４０２）を含む組成物
US20250025522A1 (en) Composition
WO2022090335A1 (en) Direct delivery of vitamins to rebalance gut microbiome after exposure to antibiotics
AU2014243769A1 (en) Prebiotic composition and method of its use
RS20170431A1 (sr) Dijetetski suplement lipozomalnog/sukrozomalnog gvožđa sa lactobacillus plantarum 299v
RU2571495C1 (ru) Способ лечения больных дисбактериозом кишечника
AU2003236417B2 (en) Methods For Reducing Cholesterol Using Bacillus Coagulans Spores, Systems And Compositions

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20180404

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191105

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20191105

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210106

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210326

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210831

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211105

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220412

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220511

R150 Certificate of patent or registration of utility model

Ref document number: 7073256

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250